Countable Labs Brings Innovative, Single-Molecule, Counting-Based PCR to European Markets with CE Mark Clearance
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, achieved CE marking for its Countable 4 Platform, a single-molecule PCR instrument for molecular quantification featuring Countable PCR technology. The platform is ideal for any genomics application where rare events need to be identified and measured completely and accurately against high background samples.
Countable Labs Announces Additional Modules for Countable PCR Expanding its Utility for Translational Research, Cell and Gene Therapy Manufacturing, and Diagnostic Development
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings direct counting of RNA to the Countable PCR platform, enabling one-step, bias-free RNA quantification, and delivering the simplicity, accuracy, and low variability essential to researchers across a range of translational, biopharma, and research applications. In addition, the company will share new data at the Association for Molecular Pathology Annual Meeting and Expo, November 11-15, 2025, in Boston, Mass.
Countable Labs Launches Revolutionary Ten-Color PCR Platform, Bridging the Gap Between PCR and Next-Generation Sequencing Technologies
Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a new benchmark for sensitivity in genomics, announced the launch of Countable 10, the first and only PCR platform capable of 10-color multiplexing. The new platform will extend the utility of the company’s core Countable PCR technology to enable higher level multiplexing that easily and cleanly reveals more insights in a single reaction. In addition, Countable Labs announced the appointment of genomics industry veteran Giovanna Prout as Chief Executive Officer, and the company plans to share Countable 10 data at the upcoming American Society of Human Genetics (ASHG) annual meeting being held October 14-18, 2025, as well as the Association for Molecular Pathology (AMP) annual meeting being held November 11-15, 2025, both in Boston, Mass.
Countable Labs Launches Category-defining, Highly Sensitive PCR Platform — Countable PCR — Finally Quantifying Rare Events, Even From Limited Samples
Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection. By delivering 10 times more sensitivity and 10 times lower CVs than digital PCR, Countable PCR gives scientists the confidence they’ve been looking for when quantifying rare events, even from limited samples.
